National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 4/23/2021 release of VAERS data:

Found 380 cases where Vaccine is HPV4 and Patient Died



Case Details (Sorted by Submission Date)

This is page 6 out of 38

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15   next


VAERS ID: 769568 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-09-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Cognitive disorder, Death
SMQs:, Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: JP0095075131809COL001613

Write-up: This spontaneous report was received from an unspecified reporter from social media refers to a female patient of unknown age. The patient''s pertinent medical history, drug reactions and allergies were not reported. Concomitant therapies were not provided. On an unknown date, the patient was vaccinated with GARDASIL (AQUEOUS SUSPENSION FOR INTRAMUSCULAR INJECTION) for prophylaxis (dose, route of administration, lot and expiration date were not reported).. On unknown dates, the patient experienced cognitive disorder and died from unspecified reason. It was not reported if an autopsy was performed. The relatedness between the events and GARDASIL (AQUEOUS SUSPENSION FOR INTRAMUSCULAR INJECTION) was not reported. This is one of several reports received from the same reporter. Follow up information has been received on 04-SEP-2018. This is a new safety report and has been created due to safety report "JP-009507513-1808JPN003267" having been submitted with an incorrect WWUID reference "JP-009507513-1808JPN003267" that does not refer to an existing case. "JP-009507513-1808JPN003267" will be nullified. The correct WWUID "CO-009507513-1809COL001613" is referenced within this safety report and will be kept as the master case file.; Sender''s Comments: CO-009507513-1806COL013012: CO-009507513-1502COL009207: CO-009507513-1507COL001112: CO-009507513-1701COL001379: CO-009507513-1506COL004105: CO-009507513-1508COL004387: JP-009507513-1808JPN004452:; Reported Cause(s) of Death: unknown cause of death.


VAERS ID: 771367 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-09-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Unevaluable event
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GB0095075131809GBR006436

Write-up: This spontaneous report was received from a consumer via local news article refers to unspecified female patients of unknown demographics. Information on patients medical history, concurrent condition and concomitant medication were not provided. On an unknown date, the patients were vaccinated with GARDASIL (dosing details, lot# and expiry date not provided) for prophylaxis. The reporter stated that unfortunately, sometimes drugs have side-effects which could be lethal. On an unknown date, the patients had died from the vaccine and there were patients (girls) who had taken their own lives due to chronic pain because it depressed them and made them feel there was no way forward(depression). The cause of death was not reported. The outcome of pain and depression were unknown. The reporter considered pain to be related to GARDASIL. This is one of the two reports received from the same reporter.; Sender''s Comments: GB-009507513-1809GBR006436: Original Case : 1809GBR006307; Reported Cause(s) of Death: unknown.


VAERS ID: 776216 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-10-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: CO0095075131810COL002319

Write-up: Information has been received in the form of a letter from a consumer regarding a case for GARDASIL (MARRS #CO-009507513-1310COL005965). The consumer reported that the GARDASIL was promoted, even though several countries, have prohibited its use because it has caused the death of 72 people (demographics unknown). The dates and causes of death were not provided. It is unknown if autopsies were performed. Upon internal review, death of 72 people was determined to be medically significant. Additional information is not expected.; Sender''s Comments: CO-009507513-1310COL005965:; Reported Cause(s) of Death: Death.


VAERS ID: 776774 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-10-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK - / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Injury, Pain
SMQs:, Accidents and injuries (narrow), Hostility/aggression (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: JP0095075131810JPN000947J

Write-up: This spontaneous report as received from a other non-medical expert refers to female patients. On an unknown date, the patient was vaccinated with GARDASIL, intramuscular (inoculation volume, lot number and the date of inoculation had not been reported). On an unknown date, severe chronic generalized pain, deaths and injuries developed. On an unknown date, patients died. The cause of death and presence/absence of an autopsy were unknown. At the time of report, the outcome of severe chronic generalized pain, deaths and injuries was unknown. Reporter''s comment: not reported. The other non-medical expert thought that severe chronic generalized pain was serious due to medically significant and not asessed the seriousness of the adverse event. The other non-medical expert did not assess the relationship betweent severe chronic generalized pain, deaths, adverse event and quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine. Reported Cause(s) of Death: Death.


VAERS ID: 779627 (history)  
Form: Version 2.0  
Age: 13.0  
Sex: Female  
Location: Foreign  
Vaccinated:2016-09-12
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-10-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / SYR

Administered by: Unknown       Purchased by: ?
Symptoms: Brain neoplasm, Death, Facial paralysis, Headache
SMQs:, Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Hearing impairment (broad), Non-haematological tumours of unspecified malignancy (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2017-11-15
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: FR0095075131810FRA007760

Write-up: This spontaneous report was received from a patient''s relative and refers to a 13 year old female patient. No information was provided regarding the patient''s medical history, concurrent conditions, previous drug reactions, allergies and concomitant medications. On 12-SEP-2016, the patient was vaccinated with her first dose of GARDASIL (strength, dose, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis. On an unspecified date in 2016, (reported as "few days following the injection"), the patient experienced daily headaches and on 29-OCT-2016, the patient presented with facial paralysis on one side of her head. Subsequently on 17-DEC-2016, (reported as "on 17 or 19 December 2016"), a magnetic resonance imaging (MRI) was performed and the patient was diagnosed with a brainstem tumor. On 15-NOV-2017, the patient died from her brainstem tumor. It was unknown whether an autopsy had been performed or not. The reporter did not consider that the patient''s brainstem tumor and subsequent death was related to GARDASIL. Upon internal review, the patient''s brainstem tumor was determined to be a medically significant event. Company Causality Assessment: Based on the limited information currently available for this case, a reasonable possibility to suggest a relationship between the GARSASIL vaccine and the reported event brain neoplasm cannot be established. Information regarding prior neurological symptoms, concurrent conditions, medical history, concomitant medications is limited and would be relevant for the case. Company Comment- No changes to the GARDASIL product safety information are warranted at this time. Merck and Co., Inc., known as MSD outside of two countries, continues to monitor the safety profile of the product. Reported Cause(s) of Death: brainstem tumor.


VAERS ID: 783202 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-11-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK - / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Cervix carcinoma, Death
SMQs:, Uterine and fallopian tube malignant tumours (narrow), Non-haematological malignant tumours (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: FR0095075131810FRA013225

Write-up: This spontaneous report was received from a physician via a lay press article concerning a female patient of unknown age who was reported to be an rowing champion. The report was also identified on the website of the physician in an article. Letter to the parliamentarians". The patient''s pertinent medical history, concurrent conditions and concomitant medications were unknown. On an unknown date, the patient was vaccinated with GARDASIL (lot#, expiry, dose, frequency and route of administration unknown) for prophylaxis. On an unknown date, the patient died at 33 years of age from cervical cancer (cervix carcinoma). It was unknown if autopsy was performed. The reporter''s causality assessment was not provided. Upon internal review, the event cervix carcinoma was determined to be medically significant. Reported Cause(s) of Death: The patient who was an champion of rowing died at 33 years from cervical cancer after being vaccinated.


VAERS ID: 783274 (history)  
Form: Version 2.0  
Age: 23.0  
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-11-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK - / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Cervix carcinoma, Death
SMQs:, Uterine and fallopian tube malignant tumours (narrow), Non-haematological malignant tumours (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2018-07-29
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: AU0095075131810AUS011861

Write-up: Information was received from an publication and an online article. On an unknown date when the female patient was 23 years old, she received the GARDASIL (lot number, dosage and route of administration not provided). No information was provided concerning the patient''s past medical history, concurrent conditions, or concomitant medication. The patient was diagnosed with cervical cancer when she was 30 years old. The patient and her family "fought for years against a terminal diagnosis." The patient shared her story before she passed away on 29-JUL-2018 and had stated that she felt very passionately about spreading the word on the destruction that GARDASIL could cause. It is unknown if an autopsy was performed. The event of cervical cancer was considered to be related to GARDASIL. Upon internal review, cervical cancer was determined to be medically significant. Additional information is not expected. Reported Cause(s) of Death: Cervical cancer.


VAERS ID: 785465 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: CA0095075131811CAN003700

Write-up: This spontaneous report was received from a physician, via a company representative, and refers to a female patient of unknown age. No information was provided regarding the patient''s medical history, concurrent conditions, previous drug reactions, allergies and concomitant medications. On an unknown date, (reported as "several years ago"), the patient was vaccinated with GARDASIL (strength, dose, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis. On an unknown date, the patient died. The cause was unknown, as well as, if an autopsy was performed or not. It was stated that the reporter was looking for more information and whether the patient had any underlying conditions. The causal relationship between therapy with GARDASIL and the patient''s death was unknown. Reported Cause(s) of Death: deceased.


VAERS ID: 785553 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK - / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Malignant atrophic papulosis
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GT0095075131811GTM004348

Write-up: This spontaneous report was received from a physician via company representative regarding a female child of unknown age. The patient was not pregnant. The patient''s medical history and concomitant medications were not reported. Her concurrent condition included "Degos Disease". On an unknown date, the patient was vaccinated with a dose of GARDASIL (route, frequency, lot# and expiration date unknown) for prophylaxis. On an unknown date, the patient died. Cause of death was not reported. It was unknown if autopsy was performed. Despite there was no relation at all with the vaccination, several parents and doctors had recommended that the patient''s death occurred due to the vaccine administration. It was reported that the patient was not hospitalized. The reporting physician who was not the patient''s pediatrician mentioned that two patients (unspecified) who had to start vaccination scheme this week, desisted due to the rumors. The reporter assessed the event to be related with the GARDASIL. Reported Cause(s) of Death: unknown cause of death.


VAERS ID: 785768 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Disease progression, Leukaemia
SMQs:, Haematological malignant tumours (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GR0095075131811GRC003149

Write-up: This spontaneous report was received from a Pediatrician, via a company representative, and refers to an adolescent female patient of unknown age (age reported as "12-13 years old"). No information was provided regarding the patient''s medical history, concurrent conditions, previous drug reactions, allergies and concomitant medications. In approximately 2013, (reported as "4-5 years ago"), the patient was vaccinated with her first dose of GARDASIL injection (strength, dose, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis. In approximately 2013, (reported as "one month later"), the patient was diagnosed with leukaemia. In approximately 2015, (reported as "two years later"), the patient deceased due to progression of leukaemia. It was unknown if an autopsy was performed or not. The reporter considered the patient''s leukaemia and subsequent death as not related to GARDASIL. Upon internal review, the patient''s leukaemia was determined to be a medically significant event. Company Causality Assessment: Based on the limited information currently available for this case, a reasonable possibility to suggest a relationship between the GARDASIL vaccine and the reported event leukemia cannot be established. Information regarding time to onset, patient''s medical history, concurrent conditions, previous drug reactions, allergies and concomitant medications, detailed clinical course are not provided and would be relevant for further assessment. Company Comment- No changes to the GARDASIL product safety information are warranted at this time. Merck and Co., Inc., known as MSD, continues to monitor the safety profile of the product. Reported Cause(s) of Death: progression of leukaemia.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=6&ESORT=SUB-DATE&VAX=HPV4&DIED=Yes


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166